<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Current Protein &amp; Peptide Science</journal-id><journal-title-group><journal-title xml:lang="en">Current Protein &amp; Peptide Science</journal-title><trans-title-group xml:lang="ru"><trans-title>Current Protein &amp; Peptide Science</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1389-2037</issn><issn publication-format="electronic">1875-5550</issn><publisher><publisher-name xml:lang="en">Bentham Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">645669</article-id><article-id pub-id-type="doi">10.2174/0113892037284176240302052521</article-id><article-categories><subj-group subj-group-type="toc-heading"><subject>Life Sciences</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Research Progress on Extracellular Matrix Involved in the Development of Preeclampsia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Xin</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Qi</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name><surname>Ren</surname><given-names>Yi</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Chao</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name><surname>Gao</surname><given-names>Huijie</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff id="aff1"><institution>School of Pharmacy, Binzhou Medical University</institution></aff><aff id="aff2"><institution>Department of Pharmacy, Shandong First Medical University &amp; Shandong Academy of Medical Sciences</institution></aff><aff id="aff3"><institution>School of Pharmacy, Jining Medical University</institution></aff><pub-date date-type="pub" iso-8601-date="2024-07-01" publication-format="electronic"><day>01</day><month>07</month><year>2024</year></pub-date><volume>25</volume><issue>7</issue><issue-title xml:lang="ru"/><fpage>527</fpage><lpage>538</lpage><history><date date-type="received" iso-8601-date="2025-01-11"><day>11</day><month>01</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Bentham Science Publishers</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Bentham Science Publishers</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://journals.eco-vector.com/1389-2037/article/view/645669">https://journals.eco-vector.com/1389-2037/article/view/645669</self-uri><abstract xml:lang="en"><p id="idm46466589561600">:Preeclampsia (PE) is a serious pregnancy complication, and its primary clinical manifestations are gestational hypertension and proteinuria. Trophoblasts are responsible for the basic functions of the placenta during placental development; recent studies have revealed that placental "shallow implantation" caused by the decreased invasiveness of placental trophoblasts plays a crucial role in PE pathogenesis. The interaction between the cells and the extracellular matrix (ECM) plays a crucial role in trophoblast proliferation, differentiation, and invasion. Abnormal ECM function can result in insufficient migration and invasion of placental trophoblasts, thus participating in PE. This article summarizes the recent studies on the involvement of ECM components, including small leucine-rich proteoglycans, syndecans, glypicans, laminins, fibronectin, collagen, and hyaluronic acid, in the development of PE. ECM plays various roles in PE development, most notably by controlling the activities of trophoblasts. The ECM is structurally stable and can serve as a biological diagnostic marker and therapeutic target for PE.</p></abstract><kwd-group xml:lang="en"><kwd>Preeclampsia</kwd><kwd>extracellular matrix</kwd><kwd>trophoblast</kwd><kwd>placenta</kwd><kwd>proteoglycans</kwd><kwd>matrix metalloproteinases.</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Van Rijn, B. B.; Bruinse, H. W.; Veerbeek, J. H.; Post Uiterweer, E. D.; Koenen, S. V.; Van der Bom, J. G.; Rijkers, G. T.; Roest, M.; Franx, A. Postpartum circulating markers of inflammation and the systemic acute-phase response after early-onset preeclampsia. Hypertension, 2016, 67(2), 402-414. doi: 10.1161/HYPERTENSIONAHA.115.06455</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Rana, S.; Lemoine, E.; Granger, J.P.; Karumanchi, S.A. Preeclampsia: Pathophysiology, challenges, and perspectives. Circ. Res., 2019, 124(7), 1094-1112. doi: 10.1161/CIRCRESAHA.118.313276 PMID: 30920918</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Chappell, L.C.; Cluver, C.A.; Kingdom, J.; Tong, S. Pre-eclampsia. Lancet, 2021, 398(10297), 341-354. doi: 10.1016/S0140-6736(20)32335-7 PMID: 34051884</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Liu, M.; Yin, Y.; Yu, H.; Zhou, R. Laminins regulate placentation and pre-eclampsia: Focus on trophoblasts and endothelial cells. Front. Cell Dev. Biol., 2020, 8, 754. doi: 10.3389/fcell.2020.00754 PMID: 32850857</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Stevens, D. U.; Al-Nasiry, S.; Bulten, J.; Spaanderman, M. E. Decidual vasculopathy in preeclampsia: Lesion characteristics relate to disease severity and perinatal outcome. Placenta, 2013, 34(9), 805-809. doi: 10.1016/j.placenta.2013.05.008</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Kalkunte, S.; Lai, Z.; Tewari, N.; Chichester, C.; Romero, R.; Padbury, J.; Sharma, S. In vitro and in vivo evidence for lack of endovascular remodeling by third trimester trophoblasts. Placenta, 2008, 29(10), 871-878. doi: 10.1016/j.placenta.2008.07.009 PMID: 18775564</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Sibai, B.; Dekker, G.; Kupferminc, M. Pre-eclampsia. Lancet, 2005, 365(9461), 785-799. doi: 10.1016/S0140-6736(05)17987-2 PMID: 15733721</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Burton, G.J.; Redman, C.W.; Roberts, J.M.; Moffett, A. Pre-eclampsia: Pathophysiology and clinical implications. BMJ, 2019, 366, l2381. doi: 10.1136/bmj.l2381 PMID: 31307997</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Velicky, P.; Meinhardt, G.; Plessl, K.; Vondra, S.; Weiss, T.; Haslinger, P.; Lendl, T.; Aumayr, K.; Mairhofer, M.; Zhu, X.; Schütz, B.; Hannibal, R.L.; Lindau, R.; Weil, B.; Ernerudh, J.; Neesen, J.; Egger, G.; Mikula, M.; Röhrl, C.; Urban, A.E.; Baker, J.; Knöfler, M.; Pollheimer, J. Genome amplification and cellular senescence are hallmarks of human placenta development. PLoS Genet., 2018, 14(10), e1007698. doi: 10.1371/journal.pgen.1007698 PMID: 30312291</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Goldman-Wohl, D, Y. S. Regulation of trophoblast invasion from normal implantation to pre-eclampsia. Mol. Cell. Endocrinol., 2002, 187(1-2), 233-238. doi: 10.1016/S0303-7207(01)00687-6</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Farrell, A.; Alahari, S.; Ermini, L.; Tagliaferro, A.; Litvack, M.; Post, M.; Caniggia, I. Faulty oxygen sensing disrupts angiomotin function in trophoblast cell migration and predisposes to preeclampsia. JCI Insight, 2019, 4(8), e127009. doi: 10.1172/jci.insight.127009 PMID: 30996134</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Shi, Z.; She, K.; Li, H.; Yuan, X.; Han, X.; Wang, Y. MicroRNA-454 contributes to sustaining the proliferation and invasion of trophoblast cells through inhibiting Nodal/ALK7 signaling in pre-eclampsia. Chem. Biol. Interact., 2019, 298, 8-14. doi: 10.1016/j.cbi.2018.10.012 PMID: 30367833</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Liu, S.; Sun, Y.; Tang, Y.; Hu, R.; Zhou, Q.; Li, X. IL-25 promotes trophoblast proliferation and invasion via binding with IL-17RB and associated with PE. Hypertens Pregnancy., 2021, 40(3), 209-217.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Armant, D.R. Blastocysts dont go it alone. Extrinsic signals fine-tune the intrinsic developmental program of trophoblast cells. Dev. Biol., 2005, 280(2), 260-280. doi: 10.1016/j.ydbio.2005.02.009 PMID: 15882572</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Abbas, Y.; Carnicer-Lombarte, A.; Gardner, L.; Thomas, J.; Brosens, J.J.; Moffett, A.; Sharkey, A.M.; Franze, K.; Burton, G.J.; Oyen, M.L. Tissue stiffness at the human maternal-fetal interface. Hum. Reprod., 2019, 34(10), 1999-2008. doi: 10.1093/humrep/dez139</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Kim, J.H.; Jekarl, D.W.; Kim, M.; Oh, E.J.; Kim, Y.; Park, I.Y.; Shin, J.C. Effects of ECM protein mimetics on adhesion and proliferation of chorion derived mesenchymal stem cells. Int. J. Med. Sci., 2014, 11(3), 298-308. doi: 10.7150/ijms.6672 PMID: 24516355</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Schaefer, L.; Schaefer, R.M. Proteoglycans: From structural compounds to signaling molecules. Cell Tissue Res., 2010, 339(1), 237-246. doi: 10.1007/s00441-009-0821-y PMID: 19513755</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Iozzo, R. V.; Schaefer, L. Proteoglycan form and function: A comprehensive nomenclature of proteoglycans. Matrix Biol, 2015, 42, 11-55. doi: 10.1016/j.matbio.2015.02.003</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Perrimon, N.; Bernfield, M. Cellular functions of proteoglycansan overview. Semin. Cell Dev. Biol., 2001, 12(2), 65-67. doi: 10.1006/scdb.2000.0237 PMID: 11292371</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Oravecz, O.; Balogh, A.; Romero, R.; Xu, Y.; Juhasz, K.; Gelencser, Z.; Xu, Z.; Bhatti, G.; Pique-Regi, R.; Peterfia, B.; Hupuczi, P.; Kovalszky, I.; Murthi, P.; Tarca, A.L.; Papp, Z.; Matko, J.; Than, N.G. Proteoglycans: Systems-level insight into their expression in healthy and diseased placentas. Int. J. Mol. Sci., 2022, 23(10), 5798. doi: 10.3390/ijms23105798 PMID: 35628608</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Chui, A.; Murthi, P.; Brennecke, S.P.; Ignjatovic, V.; Monagle, P.T.; Said, J.M. The expression of placental proteoglycans in pre-eclampsia. Gynecol. Obstet. Invest., 2012, 73(4), 277-284. doi: 10.1159/000333262 PMID: 22516801</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Merline, R.; Schaefer, R.M.; Schaefer, L. The matricellular functions of small leucine-rich proteoglycans (SLRPs). J. Cell Commun. Signal., 2009, 3(3-4), 323-335. doi: 10.1007/s12079-009-0066-2 PMID: 19809894</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Low, S.W.Y.; Connor, T.B.; Kassem, I.S.; Costakos, D.M.; Chaurasia, S.S. Small leucine-rich proteoglycans (SLRPs) in the retina. Int. J. Mol. Sci., 2021, 22(14), 7293. doi: 10.3390/ijms22147293 PMID: 34298915</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Pang, X.; Dong, N.; Zheng, Z. Small leucine-rich proteoglycans in skin wound healing. Front. Pharmacol., 2020, 10, 1649. doi: 10.3389/fphar.2019.01649 PMID: 32063855</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Naito, Z. Role of the small leucine-rich proteoglycan (SLRP) family in pathological lesions and cancer cell growth. J. Nippon Med. Sch., 2005, 72(3), 137-145. doi: 10.1272/jnms.72.137 PMID: 16046829</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Schaefer, L.; Iozzo, R.V. Biological functions of the small leucine-rich proteoglycans: From genetics to signal transduction. J. Biol. Chem., 2008, 283(31), 21305-21309. doi: 10.1074/jbc.R800020200 PMID: 18463092</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Neill, T.; Schaefer, L.; Iozzo, R.V. Decorin: A guardian from the matrix. Am. J. Pathol., 2012, 181(2), 380-387. doi: 10.1016/j.ajpath.2012.04.029 PMID: 22735579</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Iacob, D.; Cai, J.; Tsonis, M.; Babwah, A.; Chakraborty, C.; Bhattacharjee, R.N.; Lala, P.K. Decorin-mediated inhibition of proliferation and migration of the human trophoblast via different tyrosine kinase receptors. Endocrinology, 2008, 149(12), 6187-6197. doi: 10.1210/en.2008-0780 PMID: 18703624</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Nandi, P.; Siddiqui, M.F.; Lala, P.K. Restraint of trophoblast invasion of the uterus by decorin: Role in pre-eclampsia. Am. J. Reprod. Immunol., 2016, 75(3), 351-360. doi: 10.1111/aji.12449 PMID: 26554635</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Lala, P.K.; Nandi, P. Mechanisms of trophoblast migration, endometrial angiogenesis in preeclampsia: The role of decorin. Cell Adhes. Migr., 2016, 10(1-2), 111-125. doi: 10.1080/19336918.2015.1106669 PMID: 26745663</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Zou, Y.; Yu, X.; Lu, J.; Jiang, Z.; Zuo, Q.; Fan, M.; Huang, S.; Sun, L. Decorin-mediated inhibition of human trophoblast cells proliferation, migration, and invasion and promotion of apoptosis in vitro. BioMed. Res. Int., 2015, 2015, 1-10. doi: 10.1155/2015/201629 PMID: 26357650</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Chakravarti, S. Primary structure of human lumican (keratan sulfate proteoglycan) and localization of the gene (LUM) to chromosome 12q21.3-q22. Genomics, 1995, 27(3), 481-488. doi: 10.1006/geno.1995.1080</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Chakravarti, S.; Petroll, W.M.; Hassell, J.R.; Jester, J.V.; Lass, J.H.; Paul, J.; Birk, D.E. Corneal opacity in lumican-null mice: Defects in collagen fibril structure and packing in the posterior stroma. Invest. Ophthalmol. Vis. Sci., 2000, 41(11), 3365-3373. PMID: 11006226</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Cornuet, P.K.B.; Blochberger, T.C.; Hassell, J.R. Molecular polymorphism of lumican during corneal development. Invest. Ophthalmol. Vis. Sci., 1994, 35(3), 870-877. PMID: 8125750</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Chen, L.; Zhang, Y.; Zuo, Y.; Ma, F.; Song, H. Lumican expression in gastric cancer and its association with biological behavior and prognosis. Oncol. Lett., 2017, 14(5), 5235-5240. doi: 10.3892/ol.2017.6842 PMID: 29098025</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Liu, C.; Hu, Y.; Wang, Z.; Pan, H.; Ren, Y.; Li, X.; Liu, Z.; Gao, H. The downregulation of placental lumican promotes the progression of preeclampsia. Reprod. Sci., 2021, 28(11), 3147-3154. doi: 10.1007/s43032-021-00660-w PMID: 34231169</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Nastase, M.V.; Young, M.F.; Schaefer, L. Biglycan: A multivalent proteoglycan providing structure and signals. J. Histochem. Cytochem., 2012, 60(12), 963-975. doi: 10.1369/0022155412456380 PMID: 22821552</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Appunni, S.; Rubens, M.; Ramamoorthy, V.; Anand, V.; Khandelwal, M.; Sharma, A. Biglycan: An emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological significance. Mol. Cell. Biochem., 2021, 476(11), 3935-3950. doi: 10.1007/s11010-021-04216-z PMID: 34181183</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Gogiel, T.; Galewska, Z.; Romanowicz, L.; Jaworski, S.; Bańkowski, E. Pre-eclampsia-associated alterations in decorin, biglycan and versican of the umbilical cord vein wall. Eur. J. Obstet. Gynecol. Reprod. Biol., 2007, 134(1), 51-56. doi: 10.1016/j.ejogrb.2006.10.003 PMID: 17097211</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Roedig, H.; Nastase, M.V.; Frey, H.; Moreth, K.; Zeng-Brouwers, J.; Poluzzi, C.; Hsieh, L.T.H.; Brandts, C.; Fulda, S.; Wygrecka, M.; Schaefer, L. Biglycan is a new high-affinity ligand for CD14 in macrophages. Matrix Biol., 2019, 77, 4-22. doi: 10.1016/j.matbio.2018.05.006 PMID: 29777767</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Schaefer, L.; Babelova, A.; Kiss, E.; Hausser, H.J.; Baliova, M.; Krzyzankova, M.; Marsche, G.; Young, M.F.; Mihalik, D.; Götte, M.; Malle, E.; Schaefer, R.M.; Gröne, H.J. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J. Clin. Invest., 2005, 115(8), 2223-2233. doi: 10.1172/JCI23755 PMID: 16025156</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Afratis, N.A.; Nikitovic, D.; Multhaupt, H.A.B.; Theocharis, A.D.; Couchman, J.R.; Karamanos, N.K. Syndecans  key regulators of cell signaling and biological functions. FEBS J., 2017, 284(1), 27-41. doi: 10.1111/febs.13940 PMID: 27790852</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Shriver, Z.; Capila, I.; Venkataraman, G.; Sasisekharan, R. Heparin and heparan sulfate: Analyzing structure and microheterogeneity. Handb. Exp. Pharmacol., 2012, 207(207), 159-176. doi: 10.1007/978-3-642-23056-1_8 PMID: 22566225</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Czarnowski, D. Syndecans in cancer: A review of function, expression, prognostic value, and therapeutic significance. Cancer Treat. Res. Commun., 2021, 27, 100312. doi: 10.1016/j.ctarc.2021.100312</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Jokimaa, V.I.S.; Kujari, H.P.; Ekholm, E.M.K.; Inki, P.L.K.; Anttila, L. Placental expression of syndecan 1 is diminished in preeclampsia. Am. J. Obstet. Gynecol., 2000, 183(6), 1495-1498. doi: 10.1067/mob.2000.107320 PMID: 11120517</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Yoneda, A.; Couchman, J.R. Regulation of cytoskeletal organization by syndecan transmembrane proteoglycans. Matrix Biol., 2003, 22(1), 25-33. doi: 10.1016/S0945-053X(03)00010-6 PMID: 12714039</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Heyer-Chauhan, N.; Ovbude, I.J.; Hills, A.A.; Sullivan, M.H.; Hills, F.A. Placental syndecan-1 and sulphated glycosaminoglycans are decreased in preeclampsia. J. Perinat. Med., 2014, 42(3), 329-338. doi: 10.1515/jpm-2013-0097 PMID: 24222257</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Novotny, W.F.; Palmier, M.; Wun, T.C.; Broze, G.J.J., Jr; Miletich, J.P. Purification and properties of heparin-releasable lipoprotein- associated coagulation inhibitor. Blood, 1991, 78(2), 394-400. doi: 10.1182/blood.V78.2.394.394 PMID: 2070077</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Elenius, K.; Määttä, A.; Salmivirta, M.; Jalkanen, M. Growth factors induce 3T3 cells to express bFGF-binding syndecan. J. Biol. Chem., 1992, 267(9), 6435-6441. doi: 10.1016/S0021-9258(18)42715-9 PMID: 1556147</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Filmus, J.; Capurro, M.; Rast, J. Glypicans. Genome Biol., 2008, 9(5), 224. doi: 10.1186/gb-2008-9-5-224 PMID: 18505598</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Khan, S.; Blackburn, M.; Mao, D.L.; Huber, R.; Schlessinger, D.; Fant, M. Glypican-3 (GPC3) expression in human placenta: Localization to the differentiated syncytiotrophoblast. Histol. Histopathol., 2001, 16(1), 71-78. doi: 10.14670/HH-16.71 PMID: 11193214</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Neaud, V.; Duplantier, J.G.; Mazzocco, C.; Kisiel, W.; Rosenbaum, J. Thrombin up-regulates tissue factor pathway inhibitor-2 synthesis through a cyclooxygenase-2-dependent, epidermal growth factor receptor-independent mechanism. J. Biol. Chem., 2004, 279(7), 5200-5206. doi: 10.1074/jbc.M306679200 PMID: 14623891</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Hohenester, E. Structural biology of laminins. Essays Biochem., 2019, 63(3), 285-295. doi: 10.1042/EBC20180075 PMID: 31092689</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Hohenester, E.; Yurchenco, P.D. Laminins in basement membrane assembly. Cell Adhes. Migr., 2013, 7(1), 56-63. doi: 10.4161/cam.21831 PMID: 23076216</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Savino, W.; Mendes-da-Cruz, D.A.; Golbert, D.C.F.; Riederer, I.; Cotta-de-Almeida, V. Laminin-mediated interactions in thymocyte migration and development. Front. Immunol., 2015, 6, 579. doi: 10.3389/fimmu.2015.00579 PMID: 26635793</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Givant-Horwitz, V.; Davidson, B.; Reich, R. Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor. Cancer Res., 2004, 64(10), 3572-3579. doi: 10.1158/0008-5472.CAN-03-3424 PMID: 15150114</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Ma, K.; Jin, H.; Hu, R.; Xiong, Y.; Zhou, S.; Ting, P.; Cheng, Y.; Yang, Y.; Yang, P.; Li, X. A proteomic analysis of placental trophoblastic cells in preeclampsia-eclampsia. Cell Biochem. Biophys., 2014, 69(2), 247-258. doi: 10.1007/s12013-013-9792-4 PMID: 24343450</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Miner, J.H.; Cunningham, J.; Sanes, J.R. Roles for laminin in embryogenesis: Exencephaly, syndactyly, and placentopathy in mice lacking the laminin alpha5 chain. J. Cell Biol., 1998, 143(6), 1713-1723. doi: 10.1083/jcb.143.6.1713 PMID: 9852162</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Zhang, X.M.; Xiong, X.; Tong, C.; Li, Q.; Huang, S.; Li, Q.S.; Liu, Y.M.; Li, H.Y.; Baker, P.; Shan, N.; Qi, H.B. Down-regulation of laminin (LN)- α5 is associated with preeclampsia and impairs trophoblast cell viability and invasiveness through PI3K signaling pathway. Cell. Physiol. Biochem., 2018, 51(5), 2030-2040. doi: 10.1159/000495822 PMID: 30522103</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Ji, Y.; Zhou, L.; Wang, G.; Qiao, Y.; Tian, Y.; Feng, Y. Role of LAMA4 gene in regulating extravillous trophoblasts in pathogenesis of preeclampsia. Med. Sci. Monit., 2019, 25, 9630-9636. doi: 10.12659/MSM.917402 PMID: 31842202</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Hynes, R. Interactions of Fibronectins; Springer-Verlag: New York, 1990, 28, pp. (11)1561-1567. doi: 10.17219/acem/104531</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Speziale, P.; Arciola, C.R.; Pietrocola, G. Fibronectin and its role in human infective diseases. Cells, 2019, 8(12), 1516. doi: 10.3390/cells8121516 PMID: 31779172</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Dalton, C.J.; Lemmon, C.A. Fibronectin: Molecular structure, fibrillar structure and mechanochemical signaling. Cells, 2021, 10(9), 2443. doi: 10.3390/cells10092443 PMID: 34572092</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Wu, H.; Liu, K.; Zhang, J. Excess fibronectin 1 participates in pathogenesis of pre-eclampsia by promoting apoptosis and autophagy in vascular endothelial cells. Mol. Hum. Reprod., 2021, 27(6), gaab030. doi: 10.1093/molehr/gaab030 PMID: 33881516</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Jiang, R.; Wang, T.; Zhou, F.; Yao, Y.; He, J.; Xu, D. Bioinformatics-based identification of miRNA-, lncRNA-, and mRNA-associated ceRNA networks and potential biomarkers for preeclampsia. Medicine, 2020, 99(45), e22985. doi: 10.1097/MD.0000000000022985 PMID: 33157942</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Tjoa, M.L.; Oudejans, C.B.M.; Van Vugt, J.M.G.; Blankenstein, M.A.; van Wijk, I.J. Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction. Hypertens. Pregnancy, 2004, 23(2), 171-189. doi: 10.1081/PRG-120028292 PMID: 15369650</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Shi, J.W.; Lai, Z.Z.; Yang, H.L.; Yang, S.L.; Wang, C.J.; Ao, D.; Ruan, L.Y.; Shen, H.H.; Zhou, W.J.; Mei, J.; Fu, Q.; Li, M.Q. Collagen at the maternal-fetal interface in human pregnancy. Int. J. Biol. Sci., 2020, 16(12), 2220-2234. doi: 10.7150/ijbs.45586 PMID: 32549767</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Heino, J. The collagen family members as cell adhesion proteins. BioEssays, 2007, 29(10), 1001-1010. doi: 10.1002/bies.20636 PMID: 17876790</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Xu, P.; W, Y.; Piao, Y.; Bai, S.; Xiao, Z.; Jia, Y.; Luo, S; Zhuang, L. Effects of matrix proteins on the expression of matrix metalloproteinase-2, -9, and -14 and tissue inhibitors of metalloproteinases in human cytotrophoblast cells during the first trimester. Biol. Reprod., 2001, 65(1), 240-246.</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>Xu, X.H.; Jia, Y.; Zhou, X.; Xie, D.; Huang, X.; Jia, L.; Zhou, Q.; Zheng, Q.; Zhou, X.; Wang, K.; Jin, L.P. Downregulation of lysyl oxidase and lysyl oxidase-like protein 2 suppressed the migration and invasion of trophoblasts by activating the TGF-β/collagen pathway in preeclampsia. Exp. Mol. Med., 2019, 51(2), 1-12. doi: 10.1038/s12276-019-0211-9 PMID: 30804321</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Feng, Y.; Chen, X.; Wang, H.; Chen, X.; Lan, Z.; Li, P.; Cao, Y.; Liu, M.; Lv, J.; Chen, Y.; Wang, Y.; Sheng, C.; Huang, Y.; Zhong, M.; Wang, Z.; Yue, X.; Huang, L.; Collagen, I. Collagen I induces preeclampsia-like symptoms by suppressing proliferation and invasion of trophoblasts. Front. Endocrinol., 2021, 12, 664766. doi: 10.3389/fendo.2021.664766 PMID: 34421817</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>Mousa, A.A.; Cappello, R.E.; Estrada-Gutierrez, G.; Shukla, J.; Romero, R.; Strauss, J.F., III; Walsh, S.W. Preeclampsia is associated with alterations in DNA methylation of genes involved in collagen metabolism. Am. J. Pathol., 2012, 181(4), 1455-1463. doi: 10.1016/j.ajpath.2012.06.019 PMID: 22863954</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>Abatangelo, G.; Vindigni, V.; Avruscio, G.; Pandis, L.; Brun, P. Hyaluronic Acid: Redefining its role. Cells, 2020, 9(7), 1743. doi: 10.3390/cells9071743 PMID: 32708202</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>Heldin, P.; Basu, K.; Olofsson, B.; Porsch, H.; Kozlova, I.; Kahata, K. Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer. J. Biochem., 2013, 154(5), 395-408. doi: 10.1093/jb/mvt085 PMID: 24092768</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation>Castellucci, M.; Kosanke, G.; Verdenelli, F.; Huppertz, B.; Kaufmann, P. Villous sprouting: Fundamental mechanisms of human placental development. Hum. Reprod. Update, 2000, 6(5), 485-494. doi: 10.1093/humupd/6.5.485 PMID: 11045879</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation>San Martin, S.; Soto-Suazo, M.; Zorn, T.M.T. Distribution of versican and hyaluronan in the mouse uterus during decidualization. Braz. J. Med. Biol. Res., 2003, 36(8), 1067-1071. doi: 10.1590/S0100-879X2003000800013 PMID: 12886461</mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation>Uzun, H.; Konukoglu, D.; Albayrak, M.; Benian, A.; Madazli, R.; Aydin, S.; Gelisgen, R.; Uludag, S. Increased maternal serum and cord blood fibronectin concentrations in preeclampsia are associated with higher placental hyaluronic acid and hydroxyproline content. Hypertens. Pregnancy, 2010, 29(2), 153-162. doi: 10.3109/10641950902968619 PMID: 20367505</mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation>Liang, J.; Jiang, D.; Griffith, J.; Yu, S.; Fan, J.; Zhao, X.; Bucala, R.; Noble, P.W. CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J. Immunol., 2007, 178(4), 2469-2475. doi: 10.4049/jimmunol.178.4.2469 PMID: 17277154</mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation>Stefańska, K.; Zieliński, M.; Jankowiak, M.; Zamkowska, D.; Sakowska, J.; Adamski, P.; Jassem-Bobowicz, J.; Piekarska, K.; Leszczyńska, K.; Świątkowska-Stodulska, R.; Kwiatkowski, S.; Preis, K.; Trzonkowski, P.; Marek-Trzonkowska, N. Cytokine imprint in preeclampsia. Front. Immunol., 2021, 12, 667841. doi: 10.3389/fimmu.2021.667841 PMID: 34248946</mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation>Sternlicht, M.D.; Werb, Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol., 2001, 17(1), 463-516. doi: 10.1146/annurev.cellbio.17.1.463 PMID: 11687497</mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation>Klein, T.; Bischoff, R. Physiology and pathophysiology of matrix metalloproteases. Amino Acids, 2011, 41(2), 271-290. doi: 10.1007/s00726-010-0689-x PMID: 20640864</mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation>Newby, A.C. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol. Rev., 2005, 85(1), 1-31. doi: 10.1152/physrev.00048.2003 PMID: 15618476</mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation>Sahay, A.S.; Jadhav, A.T.; Sundrani, D.P.; Wagh, G.N.; Mehendale, S.S.; Joshi, S.R. Matrix metalloproteinases-2 (MMP-2) and matrix metalloproteinases-9 (MMP-9) are differentially expressed in different regions of normal and preeclampsia placentae. J. Cell. Biochem., 2018, 119(8), 6657-6664. doi: 10.1002/jcb.26849 PMID: 29665148</mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation>Suo, M.; Sun, Y.; Yang, H.; Ji, J.; He, Y.; Dong, L.; Wang, Y.; Zhang, Y.; Zhang, Y.; Hao, M. miR-183-5p suppressed the invasion and migration of HTR-8/SVneo trophoblast cells partly via targeting MMP-9 in preeclampsia. Biosci. Rep., 2020, 40(6), BSR20192575. doi: 10.1042/BSR20192575 PMID: 32342983</mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation>Timokhina, E.; Strizhakov, A.; Ibragimova, S.; Gitel, E.; Ignatko, I.; Belousova, V.; Zafiridi, N. Matrix metalloproteinases MMP-2 and MMP-9 occupy a new role in severe preeclampsia. J. Pregnancy, 2020, 2020(1-2), 1-7. doi: 10.1155/2020/8369645 PMID: 33381317</mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation>Ng, E.K.O.; Leung, T.N.; Tsui, N.B.Y.; Lau, T.K.; Panesar, N.S.; Chiu, R.W.K.; Lo, Y.M.D. The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. Clin. Chem., 2003, 49(5), 727-731. doi: 10.1373/49.5.727 PMID: 12709362</mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation>Nishikawa, S.; Miyamoto, A.; Yamamoto, H.; Ohshika, H.; Kudo, R. The relationship between serum nitrate and endothelin-1 concentrations in preeclampsia. Life Sci., 2000, 67(12), 1447-1454. doi: 10.1016/S0024-3205(00)00736-0 PMID: 10983841</mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation>Cohen, M.; Ribaux, P.; Epiney, M.; Irion, O. Expression of metalloproteinases 1, 2, 7, 9, and 12 in human cytotrophoblastic cells from normal and preeclamptic placentas. Neuroendocrinol. Lett., 2012, 33(4), 406-411. PMID: 22936257</mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation>Page-McCaw, A.; Ewald, A.J.; Werb, Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol., 2007, 8(3), 221-233. doi: 10.1038/nrm2125 PMID: 17318226</mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation>Khan, G.A.; Girish, G.V.; Lala, N.; Di Guglielmo, G.M.; Lala, P.K. Decorin is a novel VEGFR-2-binding antagonist for the human extravillous trophoblast. Mol. Endocrinol., 2011, 25(8), 1431-1443. doi: 10.1210/me.2010-0426 PMID: 21659473</mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation>Siddiqui, M. F.; Nandi, P.; Girish, G. V.; Nygard, K.; Eastabrook, G.; de Vrijer, B.; Han, V. K.; Lala, P. K. Decorin over-expression by decidual cells in preeclampsia: A potential blood biomarker. Am J Obstet Gynecol, 2016, 215(3), 361 e1-361 e6. doi: 10.1016/j.ajog.2016.03.020</mixed-citation></ref></ref-list></back></article>
